UBS Group’s Cross Country Healthcare CCRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.44M | Sell |
187,032
-119,533
| -39% | -$1.56M | ﹤0.01% | 3659 |
|
2025
Q1 | $4.56M | Buy |
306,565
+175,874
| +135% | +$2.62M | ﹤0.01% | 3036 |
|
2024
Q4 | $2.37M | Sell |
130,691
-311,110
| -70% | -$5.65M | ﹤0.01% | 3589 |
|
2024
Q3 | $5.94M | Buy |
441,801
+76,889
| +21% | +$1.03M | ﹤0.01% | 2123 |
|
2024
Q2 | $5.05M | Buy |
364,912
+337,214
| +1,217% | +$4.67M | ﹤0.01% | 2129 |
|
2024
Q1 | $519K | Sell |
27,698
-16,747
| -38% | -$314K | ﹤0.01% | 4080 |
|
2023
Q4 | $1.01M | Buy |
44,445
+26,529
| +148% | +$601K | ﹤0.01% | 3437 |
|
2023
Q3 | $444K | Sell |
17,916
-17,302
| -49% | -$429K | ﹤0.01% | 3686 |
|
2023
Q2 | $989K | Buy |
35,218
+2,857
| +9% | +$80.2K | ﹤0.01% | 3311 |
|
2023
Q1 | $722K | Sell |
32,361
-25,497
| -44% | -$569K | ﹤0.01% | 3434 |
|
2022
Q4 | $1.54M | Buy |
57,858
+42,755
| +283% | +$1.14M | ﹤0.01% | 2774 |
|
2022
Q3 | $429K | Buy |
+15,103
| New | +$429K | ﹤0.01% | 3496 |
|
2022
Q2 | – | Sell |
-17,874
| Closed | -$387K | – | 9277 |
|
2022
Q1 | $387K | Sell |
17,874
-4,542
| -20% | -$98.3K | ﹤0.01% | 3923 |
|
2021
Q4 | $622K | Buy |
22,416
+21,567
| +2,540% | +$598K | ﹤0.01% | 3817 |
|
2021
Q3 | $18K | Buy |
849
+298
| +54% | +$6.32K | ﹤0.01% | 6130 |
|
2021
Q2 | $9K | Sell |
551
-11,903
| -96% | -$194K | ﹤0.01% | 7023 |
|
2021
Q1 | $156K | Sell |
12,454
-10,096
| -45% | -$126K | ﹤0.01% | 4662 |
|
2020
Q4 | $200K | Buy |
22,550
+11,453
| +103% | +$102K | ﹤0.01% | 4275 |
|
2020
Q3 | $72K | Sell |
11,097
-5,207
| -32% | -$33.8K | ﹤0.01% | 4557 |
|
2020
Q2 | $100K | Sell |
16,304
-7,799
| -32% | -$47.8K | ﹤0.01% | 4483 |
|
2020
Q1 | $162K | Sell |
24,103
-23,751
| -50% | -$160K | ﹤0.01% | 4048 |
|
2019
Q4 | $557K | Buy |
47,854
+16,282
| +52% | +$190K | ﹤0.01% | 3811 |
|
2019
Q3 | $325K | Buy |
31,572
+16,209
| +106% | +$167K | ﹤0.01% | 4025 |
|
2019
Q2 | $144K | Buy |
15,363
+7,924
| +107% | +$74.3K | ﹤0.01% | 4309 |
|
2019
Q1 | $52K | Sell |
7,439
-13,226
| -64% | -$92.5K | ﹤0.01% | 4697 |
|
2018
Q4 | $152K | Buy |
20,665
+3,862
| +23% | +$28.4K | ﹤0.01% | 4312 |
|
2018
Q3 | $147K | Buy |
16,803
+4,833
| +40% | +$42.3K | ﹤0.01% | 4427 |
|
2018
Q2 | $135K | Buy |
11,970
+2,030
| +20% | +$22.9K | ﹤0.01% | 4361 |
|
2018
Q1 | $111K | Buy |
9,940
+633
| +7% | +$7.07K | ﹤0.01% | 4329 |
|
2017
Q4 | $118K | Buy |
9,307
+158
| +2% | +$2K | ﹤0.01% | 4316 |
|
2017
Q3 | $130K | Buy |
9,149
+976
| +12% | +$13.9K | ﹤0.01% | 4294 |
|
2017
Q2 | $106K | Buy |
8,173
+2,977
| +57% | +$38.6K | ﹤0.01% | 4246 |
|
2017
Q1 | $75K | Sell |
5,196
-7,995
| -61% | -$115K | ﹤0.01% | 4365 |
|
2016
Q4 | $206K | Buy |
13,191
+4,489
| +52% | +$70.1K | ﹤0.01% | 3906 |
|
2016
Q3 | $102K | Sell |
8,702
-9,240
| -51% | -$108K | ﹤0.01% | 4137 |
|
2016
Q2 | $250K | Sell |
17,942
-26,143
| -59% | -$364K | ﹤0.01% | 3616 |
|
2016
Q1 | $513K | Buy |
44,085
+7,467
| +20% | +$86.9K | ﹤0.01% | 3104 |
|
2015
Q4 | $600K | Buy |
36,618
+28,111
| +330% | +$461K | ﹤0.01% | 3025 |
|
2015
Q3 | $116K | Buy |
8,507
+4,293
| +102% | +$58.5K | ﹤0.01% | 4104 |
|
2015
Q2 | $54K | Buy |
4,214
+3,739
| +787% | +$47.9K | ﹤0.01% | 4728 |
|
2015
Q1 | $6K | Sell |
475
-2,927
| -86% | -$37K | ﹤0.01% | 6108 |
|
2014
Q4 | $42K | Buy |
+3,402
| New | +$42K | ﹤0.01% | 4867 |
|